PIEZO2 Gene Marden-Walker Syndrome NGS Genetic DNA Test
Introduction
The PIEZO2 Gene Marden-Walker Syndrome NGS Genetic DNA Test is a vital diagnostic tool that assesses genetic mutations associated with Marden-Walker syndrome, a rare neurological disorder. This test utilizes Next-Generation Sequencing (NGS) technology to provide accurate results, enabling healthcare providers to make informed decisions regarding patient care and management.
What the Test Measures
This genetic test specifically detects mutations in the PIEZO2 gene, which are linked to Marden-Walker syndrome. By identifying these mutations, the test helps in confirming a diagnosis and understanding the genetic basis of the disorder.
Who Should Consider This Test
Individuals who exhibit symptoms such as developmental delays, neurological issues, and other related health concerns should consider this test. Additionally, those with a family history of Marden-Walker syndrome or similar neurological disorders are encouraged to undergo testing.
Benefits of Taking the Test
- Accurate diagnosis of Marden-Walker syndrome.
- Guidance for family planning and management of the disorder.
- Access to specialized care from neurologists and genetic counselors.
- Peace of mind through understanding genetic risks.
Understanding Your Results
Results from the PIEZO2 Gene Marden-Walker Syndrome NGS Genetic DNA Test will be provided alongside a comprehensive report explaining the findings. It is essential to consult with a genetic counselor or neurologist to interpret the results accurately and discuss potential next steps.
Test Information and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| PIEZO2 Gene Marden-Walker Syndrome NGS Genetic DNA Test | 400000 NGN | 560000 NGN |
Booking Your Test
To book the PIEZO2 Gene Marden-Walker Syndrome NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you with scheduling your appointment and providing any additional information you may need.
Additional Information
Turnaround time for results is typically 3 to 4 weeks. The sample type required for this test includes blood, extracted DNA, or one drop of blood on an FTA card. Prior to testing, a clinical history of the patient and a genetic counseling session to draw a pedigree chart of affected family members are recommended.
Consult with a neurologist or genetic specialist to determine if this test is appropriate for you or your family members.
